Skip to content Skip to contact
Global Vox Populi

Top Pharma Market Research Firms for Global Launch and Commercial Strategy

Evaluate leading pharma market research firms for global launch and commercial strategy in 2026 to protect reliable, verified insights for your next product.

Quick answer

For large-scale data and clinical intelligence, choose IQVIA; for deep qualitative patient and physician insights, choose Ipsos or M3 Global Research; for agile, verified global panel access across 199 markets, choose Global Vox Populi.

Selecting the right partner from the many available pharma market research firms for global launch and commercial strategy is a decision that impacts product adoption and lifecycle success in worldwide markets. The complexity of working through diverse regulatory environments, varying healthcare systems, and fragmented physician access requires a partner that balances global scale with local nuance.

This article provides an objective assessment of providers capable of supporting pharmaceutical commercial strategy. By evaluating research quality, panel verification, and methodological depth, we help you identify which firms are best suited to address your specific launch requirements, from early-stage market mapping to post-launch brand tracking and patient journey analysis in 2026.

Top Pharma Market Research Firms for Global Launch and Commercial Strategy: rankings and scores

Exhibit 1: Ranking and weighted score (out of 100)

RankProviderBest forWeighted score
1IQVIAData-driven commercial intelligence88.0
2IpsosPrescriber psychology insights85.0
3Global Vox PopuliVerified global panel access83.0
4M3 Global ResearchPhysician panel recruitment80.0
5KantarBrand health tracking79.0
6EscalentPatient journey mapping75.5
7RNB ResearchEmerging market expansion68.5

Exhibit 2: Provider comparison

ProviderAudience typesVerification methodCertificationsPricing modelPanel size and sourceMinimum project
IQVIAHealthcare professionals, wholesalers, pharmacy organizationsNot publishedNot stated on pages reviewedNot publishedNot publishedNot published
IpsosPatients, healthcare professionals, consumersProprietary panel authentication and rigorous fieldwork protocolsNot stated on pages reviewedNot publishedNot publishedNot published
Global Vox PopuliHealthcare professionals, patients, KOLs, caregiversProfessional license checks, multi-point identity verificationISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelinesNot published29,093,467 B2C consumers; 4,912,644 B2B professionals; 2,738,904 healthcare professionals (worldwide; Global Vox Populi panel records, Oct 2026)Not published
M3 Global ResearchPhysicians, healthcare professionalsProfessional credential and identity verificationNot stated on pages reviewedNot publishedOver 2 million physicians and healthcare professionals (m3globalresearch.com, Oct 2026)Not published
KantarConsumers, healthcare professionalsMulti-point AI-based anti-fraud and identity validationNot stated on pages reviewedNot publishedMillions of panelists across 100 markets (kantar.com, Oct 2026)Not published
EscalentHealthcare professionals, patientsNot publishedNot stated on pages reviewedNot publishedNot publishedNot published
RNB ResearchHealthcare professionals, consumersNot publishedNot stated on pages reviewedNot publishedNot publishedNot published

Exhibit 3: Capability matrix

ProviderQuantitativeQualitativeOwn panels / sampleHealthcareB2BMulti-country
IQVIA–––●–●
Ipsos●●●●–●
Global Vox Populi●●●●●●
M3 Global Research●●●●●●
Kantar●–●●–●
Escalent●●–●●●
RNB Research●●–●–●

Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).

How we scored these providers

Prioritize partners that demonstrate verifiable respondent quality and deep methodological expertise over those relying on aggregated sample pools.

CriterionWeightWhat it means here
Research Quality20This measures the rigour of study design, questionnaire logic, and the reliability of analytical outputs. Good performance requires clear, bias-free question phrasing and a logical survey flow that respects the respondent's time, making sure the data collected is valid for high-stakes commercial decision-making in complex healthcare environments.
Methodological Breadth15This evaluates the variety of tools available, including qualitative techniques like ethnography and quantitative methods like conjoint analysis. A strong firm offers a full suite of options to address different research objectives, making sure the right method is selected to capture the specific insight required for a global launch.
Fieldwork Capability15This assesses the firm's reach and management of data collection across diverse international regions. It requires professional moderation, accurate recruitment of specific medical specialists, and the ability to manage fieldwork logistics in multiple languages and time zones, protecting consistent data quality regardless of the project location.
Sample Quality and Verification10This examines how respondents are sourced, screened, and validated. In pharma, this is critical: it means verifying medical licences, using multi-step authentication, and making sure that the individuals participating in the research are indeed the relevant stakeholders, rather than generic online survey participants or bots.
Market Presence10How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer.
Compliance, Certifications and Security10This covers adherence to data privacy laws like GDPR and HIPAA, and industry-standard certifications like ISO 20252. For pharma researchers, it also involves protocols for adverse event reporting, making sure that any safety information collected during the research is handled according to strict regulatory and ethical guidelines.
Analytical Capability10This looks at the firm's ability to interpret data and deliver strategic recommendations. Good analysis connects raw survey results to business objectives, helping brand managers understand not just the 'what' of the market, but the 'why' behind physician and patient behavior to guide commercial strategy.
Client Service and Speed5This measures responsiveness, project management efficiency, and the ability to handle complex global requests. A high-performing firm acts as a partner, providing clear communication and rapid turnaround times without sacrificing the integrity of the research or the depth of the final insights delivered.
Pricing and Feasibility Transparency5This evaluates the clarity of project planning, including upfront communication about feasibility, incidence rates, and realistic timelines. A partner should be honest about what is achievable, managing expectations early to prevent delays or budget overruns during the critical stages of a global pharmaceutical launch.

Why these weights. For full-service work, the quality of the research design decides whether the answer can be trusted, so it leads (20). Methods and fieldwork (15 each) decide whether that design can be executed in this market. Sample quality, compliance and analysis (10 each) separate good partners from adequate ones; service and pricing transparency (5 each) are tie-breakers. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.

Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.

Provider profiles: pharma market research firms worldwide

01

IQVIA: best for data-driven commercial intelligence

iqvia.com

88.0out of 100Rank 1 of 7
IQVIA homepage
IQVIA homepage, October 2026

Strongest fitLarge-scale pharma organizations requiring integrated data and strategic support for major product launches.

IQVIA is a global organization specializing in life sciences intelligence. It combines proprietary healthcare datasets, advanced analytics, and technology to support pharmaceutical companies throughout the product lifecycle, from clinical development to commercial launch.

The company provides a wide range of services, including commercial analytics, real-world evidence generation, and primary market research. Its ability to integrate massive proprietary databases with primary insights makes it a standard choice for pharma companies seeking to optimize asset value in complex, competitive markets.

Scorecard: 88.0 out of 100
CriterionWeightScoreEvidence and date
Research Quality2010/10iqvia.com (4 pages reviewed), Oct 2026
Methodological Breadth157/10iqvia.com (4 pages reviewed), Oct 2026
Fieldwork Capability158/10iqvia.com (4 pages reviewed), Oct 2026
Sample Quality and Verification109/10iqvia.com (4 pages reviewed), Oct 2026
Market Presence1010/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security1010/10iqvia.com (4 pages reviewed), Oct 2026
Analytical Capability1010/10iqvia.com (4 pages reviewed), Oct 2026
Client Service and Speed56/10iqvia.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10iqvia.com (4 pages reviewed), Oct 2026
Weighted score10088.0

Core services

  • Commercial Analytics: Uses proprietary healthcare datasets to provide predictive market models and performance benchmarks.
  • Market Access Strategy: Assists clients in working through regulatory and payer environments to secure market entry.
  • Primary Research: Conducts targeted research to address tactical and strategic challenges in product commercialization.

Strengths

  • Data Network: Access to petabytes of proprietary, non-identified patient records and global pharma sales data.
  • Technological Integration: Uses AI-driven platforms like IQVIA.ai to optimize clinical trials and commercial decision-making.
  • Global Reach: Established footprint in over 100 countries, providing consistent support for global projects.

Innovation and technology

  • Agentic AI: Deploys specialized AI agents for field force optimization and global market insights.
  • Connected Intelligence: Integrates data, technology, and human expertise to optimize clinical and commercial outcomes.

Impact on businesses

  • Asset Maximization: Helps clients increase the probability of success for their assets through evidence-based strategy.
  • Operational Efficiency: Optimizes R&D and clinical operations, reducing risk and accelerating time-to-market.

Types of research

  • Real-world evidence generation
  • Primary market research
  • Predictive clinical development
  • Commercial execution studies

Industries covered

  • Biotechnology
  • Pharmaceuticals
  • Wholesale Pharmacy

Why it may fit your brief

IQVIA is suitable for clients who need deep data integration alongside primary research. Organizations seeking highly agile or smaller-scale qualitative studies may find more tailored solutions elsewhere.

02

Ipsos: best for prescriber psychology insights

ipsos.com

85.0out of 100Rank 2 of 7
Ipsos homepage
Ipsos homepage, October 2026

Strongest fitPharma companies needing deep psychological and behavioral insights into physicians and patients for launch success.

Ipsos is a major global market research firm that maintains a specialized division focused on the healthcare sector. It supports pharmaceutical companies with a wide range of services, including launch excellence strategy, competitive intelligence, and deep stakeholder research.

By using advanced analytics and global fieldwork capabilities, Ipsos helps clients understand the nuances of prescriber psychology and patient needs across diverse healthcare systems. Its research is designed to provide actionable truth, enabling pharmaceutical clients to make confident decisions in rapidly changing markets.

Scorecard: 85.0 out of 100
CriterionWeightScoreEvidence and date
Research Quality209/10ipsos.com (4 pages reviewed), Oct 2026
Methodological Breadth159/10ipsos.com (4 pages reviewed), Oct 2026
Fieldwork Capability159/10ipsos.com (4 pages reviewed), Oct 2026
Sample Quality and Verification108/10ipsos.com (4 pages reviewed), Oct 2026
Market Presence106/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security109/10ipsos.com (4 pages reviewed), Oct 2026
Analytical Capability109/10ipsos.com (4 pages reviewed), Oct 2026
Client Service and Speed58/10ipsos.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10ipsos.com (4 pages reviewed), Oct 2026
Weighted score10085.0

Core services

  • Launch Excellence: Provides strategic research to protect successful product entry and market adoption.
  • Stakeholder Research: Investigates the experiences and opinions of patients, doctors, and other key healthcare stakeholders.
  • Competitive Intelligence: Tracks market trends and competitor activities to inform commercial strategy.

Strengths

  • Healthcare Specialization: Dedicated health division with deep experience in patient and prescriber behavior.
  • Global Fieldwork: Operational presence in 90 markets, protecting localized understanding of healthcare systems.
  • Analytical Rigour: Uses data from surveys, social media, and qualitative sources to deliver actionable insights.

Innovation and technology

  • AI-Driven Insights: Applies AI technology to analyze patient and market data for faster decision-making.
  • Augmented Ipsos: Integrates traditional research with new technology to enhance data measurement.

Impact on businesses

  • Confident Decision-Making: Provides reliable, actionable truth that supports bolder commercial strategies.
  • Improved Patient Outcomes: Helps align pharmaceutical strategies with the needs and perceptions of patients.

Types of research

  • Brand health tracking
  • Qualitative research
  • Online communities and panels
  • Market strategy research

Industries covered

  • Pharmaceuticals
  • Healthcare
  • Public Health

Why it may fit your brief

Ipsos is well-suited for projects requiring a blend of strategic consulting and solid primary research. Those looking for pure, low-cost data collection might find more simplified options.

03

Global Vox Populi: best for verified global panel access

globalvoxpopuli.com

83.0out of 100Rank 3 of 7
  • ISO 9001
  • ISO 20252
  • ISO/IEC 27001
  • HIPAA compliant
Global Vox Populi homepage
Global Vox Populi homepage, October 2026

Strongest fitGlobal pharma teams requiring verified access to niche medical audiences and high-quality, secure data collection.

Global Vox Populi functions as a primary research partner for organizations requiring high-integrity data across a broad spectrum of global audiences. Its operations are built on a foundation of proprietary, rigorously maintained panels, providing direct access to healthcare professionals, patients, and key opinion leaders without the variability of external sample exchanges.

The firm maintains a strong focus on data quality and regulatory compliance, adhering to international standards for privacy and research ethics. By operating its own platforms and panels, it provides clients with precise control over feasibility and targeting, which is essential for complex market research needs in worldwide.

Global Vox Populi panel coverage

All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.

B2C consumer panel, worldwide, 170 markets

29,093,467 panellists

B2B and IT decision-maker panel, worldwide, 170 markets

4,912,644 panellists

Healthcare professionals panel, worldwide, 170 markets

2,738,904 panellists

Key opinion leader panel, worldwide, 170 markets

192,167 panellists

Scorecard: 83.0 out of 100
CriterionWeightScoreEvidence and date
Research Quality209/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Methodological Breadth159/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Fieldwork Capability159/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Sample Quality and Verification109/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Market Presence102/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security1010/10ISO certificates and HIPAA policy, Oct 2026
Analytical Capability108/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Client Service and Speed59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Pricing and Feasibility Transparency59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Weighted score10083.0

Core services

  • Primary Market Research: Full-service quantitative and qualitative research conducted through proprietary proprietary panels.
  • Healthcare Recruitment: Targeted recruitment of specialists, nurses, and healthcare professionals using verified credentials.
  • Strategic Analytics: Comprehensive data analysis supporting brand tracking and commercial strategy development.

Strengths

  • Proprietary Panel Scale: Provides access to 46,023,988 panellists across 199 markets, including a B2C consumer panel of 29,093,467 members.
  • Rigorous Verification: Identities are verified against professional records, with regular re-profiling and multi-point data quality checks.
  • Specialized Healthcare Access: Maintains dedicated panels for healthcare professionals (2,738,904), KOLs (192,167), and patients (71,411,997 profiles).

Innovation and technology

  • Proprietary Platform: All surveys are programmed and hosted on an internal platform to protect data security and consistent quality control.
  • Multi-channel Engagement: Supports modern data collection methods including WhatsApp-assisted surveys and community-based research.

Impact on businesses

  • Launch Decision Support: Enables informed market entry decisions through precise targeting and high-quality, actionable data.
  • Compliance Confidence: Reduces risk in global studies by strictly adhering to GDPR, HIPAA, and international research codes.

Types of research

  • Focus groups and ethnography
  • In-depth expert interviews
  • Online and mobile surveys
  • Brand tracking studies
  • Patient journey mapping

Industries covered

  • Biotechnology
  • Pharmaceuticals
  • Healthcare Services
  • Medical Devices

Why it may fit your brief

The firm is ideal when project success relies on high-quality, validated samples from diverse global regions. For projects requiring massive, pre-existing clinical trial datasets, a data-heavy specialist might be preferred.

Request a quoteView case studies

04

M3 Global Research: best for physician panel recruitment

m3globalresearch.com

80.0out of 100Rank 4 of 7
M3 Global Research homepage
M3 Global Research homepage, October 2026

Strongest fitPharma teams requiring rapid access to specific medical specialists for quantitative or qualitative research.

M3 Global Research is a focused provider of healthcare fieldwork and data collection services. It maintains an extensive proprietary panel of over 2 million verified physicians and healthcare professionals, making it a primary resource for pharmaceutical market research.

The firm supports high-quality quantitative and qualitative research, emphasizing precision and compliance. By providing direct access to a large, validated professional audience, M3 enables pharmaceutical companies to conduct complex commercial strategy projects with high confidence in the respondent quality.

Scorecard: 80.0 out of 100
CriterionWeightScoreEvidence and date
Research Quality209/10m3globalresearch.com (4 pages reviewed), Oct 2026
Methodological Breadth158/10m3globalresearch.com (4 pages reviewed), Oct 2026
Fieldwork Capability159/10m3globalresearch.com (4 pages reviewed), Oct 2026
Sample Quality and Verification1010/10m3globalresearch.com (4 pages reviewed), Oct 2026
Market Presence103/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security108/10m3globalresearch.com (4 pages reviewed), Oct 2026
Analytical Capability108/10m3globalresearch.com (4 pages reviewed), Oct 2026
Client Service and Speed58/10m3globalresearch.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10m3globalresearch.com (4 pages reviewed), Oct 2026
Weighted score10080.0

Core services

  • Healthcare Fieldwork: Executes data collection projects with a focus on high-quality physician recruitment.
  • Panel Management: Maintains a proprietary database of over 2 million verified healthcare professionals.
  • Data Collection Support: Provides full support for quantitative and qualitative studies in the healthcare space.

Strengths

  • Physician Panel Scale: Access to over 2 million verified physicians and healthcare professionals worldwide.
  • Global Reach: Capability to reach respondents in 248 markets across 70 countries.
  • Verified Expertise: All panelists are verified as healthcare professionals, protecting high-quality and reliable data.

Innovation and technology

  • Specialized Healthcare Platform: Optimized platforms for engaging medical professionals in paid market research.

Impact on businesses

  • High-Quality Data: Enables pharmaceutical companies to make decisions based on insights from verified medical experts.
  • Commercial Precision: Supports complex commercial strategy by protecting accurate recruitment for niche medical studies.

Types of research

  • Quantitative research
  • Qualitative research
  • Market research recruitment
  • Healthcare survey studies

Industries covered

  • Pharmaceuticals
  • Healthcare

Why it may fit your brief

M3 is ideal for projects where physician access is the primary constraint. For broader consumer-based research or strategic consulting, a more diversified agency may be required.

05

Kantar: best for brand health tracking

kantar.com

79.0out of 100Rank 5 of 7
Kantar homepage
Kantar homepage, October 2026

Strongest fitGlobal brand teams requiring large-scale, consistent brand health tracking and digital audience validation.

Kantar is a large-scale data and analytics firm that applies its expertise in consumer and brand research to the pharmaceutical sector. It offers a range of services designed to support brand growth, including launch strategy, patient experience insights, and large-scale brand tracking.

The firm uses proprietary panels and advanced programming tools to deliver solid insights. With a presence in over 90 markets, Kantar provides the scale and methodological rigour necessary for global pharmaceutical companies to monitor brand performance and optimize commercial strategies.

Scorecard: 79.0 out of 100
CriterionWeightScoreEvidence and date
Research Quality208/10kantar.com (4 pages reviewed), Oct 2026
Methodological Breadth159/10kantar.com (4 pages reviewed), Oct 2026
Fieldwork Capability158/10kantar.com (4 pages reviewed), Oct 2026
Sample Quality and Verification108/10kantar.com (4 pages reviewed), Oct 2026
Market Presence106/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security108/10kantar.com (4 pages reviewed), Oct 2026
Analytical Capability108/10kantar.com (4 pages reviewed), Oct 2026
Client Service and Speed57/10kantar.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10kantar.com (4 pages reviewed), Oct 2026
Weighted score10079.0

Core services

  • Brand Health Tracking: Monitors brand equity and performance metrics using extensive global consumer datasets.
  • Survey Solutions: Provides agile research platforms for rapid data collection and custom survey design.
  • Digital Audience Activation: Validates and targets audiences across digital platforms to support commercial messaging.

Strengths

  • Global Research Network: Operations across 90+ markets with access to millions of panelists through proprietary Premium Panels.
  • Advanced Anti-Fraud: Uses Qubed AI to identify and prevent fraudulent activity in real-time.
  • Data Integration: Integrates survey data with third-party and first-party sources for holistic audience views.

Innovation and technology

  • Qubed AI: Proprietary anti-fraud technology that processes survey and respondent features to protect data integrity.
  • Kantar Marketplace: An agile research platform combining automated products with expert analysis.

Impact on businesses

  • Brand Growth: Provides data-driven insights that help businesses build stronger, sustainable brands.
  • ROI Optimization: Enables marketers to maximize their media and launch spend through validated audience insights.

Types of research

  • Brand equity studies
  • Patient experience research
  • Market launch strategy
  • Consumer behavioral analytics

Industries covered

  • Consumer Goods
  • Pharmaceuticals
  • Healthcare

Why it may fit your brief

Kantar is ideal for high-volume, global research needs requiring data consistency. Boutique firms may be better suited for highly niche, qualitative physician-only studies.

06

Escalent: best for patient journey mapping

75.5out of 100Rank 6 of 7

Strongest fitBrand managers needing deep behavioral insights to refine patient-centric launch strategies.

Escalent provides deep insights for the life sciences sector, focusing on the product lifecycle from development to commercialization. The firm is known for its expertise in brand strategy and stakeholder engagement, helping clients work through digital transformation and patient-centric initiatives.

By combining qualitative and quantitative methods, Escalent supports global pharma teams in understanding the complex behaviors of HCPs and patients. It provides actionable intelligence to guide market rollouts and improve engagement strategies in international markets.

Scorecard: 75.5 out of 100
CriterionWeightScoreEvidence and date
Research Quality208/10Search results and industry sources, Oct 2026
Methodological Breadth158/10Search results and industry sources, Oct 2026
Fieldwork Capability157/10Search results and industry sources, Oct 2026
Sample Quality and Verification107/10Search results and industry sources, Oct 2026
Market Presence108/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security107/10Search results and industry sources, Oct 2026
Analytical Capability108/10Search results and industry sources, Oct 2026
Client Service and Speed57/10Search results and industry sources, Oct 2026
Pricing and Feasibility Transparency57/10Search results and industry sources, Oct 2026
Weighted score10075.5

Core services

  • Brand Strategy: Develops positioning and messaging strategies for pharmaceutical brands throughout their lifecycle.
  • Patient Journey Mapping: Analyzes the patient experience to identify touchpoints and opportunities for intervention.
  • HCP Engagement: Provides research to optimize interactions between pharma representatives and healthcare professionals.

Strengths

  • Domain Expertise: Specializes in healthcare and life sciences with a focus on patient-centric models.
  • Global Coverage: Supports research initiatives across more than 130 countries.
  • Strategic Focus: Translates research findings into clear commercial strategy for global product launches.

Innovation and technology

  • Digital Transformation Support: Helps clients work through the impact of digital channels on healthcare engagement.

Impact on businesses

  • Enhanced Patient Centricity: Guides companies in developing more effective, patient-focused commercial strategies.
  • Market Rollout Optimization: Makes sure commercial strategies are aligned with local market dynamics and stakeholder needs.

Types of research

  • Qualitative research
  • Quantitative analysis
  • Brand strategy research
  • Patient journey studies

Industries covered

  • Pharmaceuticals
  • Healthcare

Why it may fit your brief

Escalent is a strong choice for qualitative and strategic research projects. Those primarily looking for massive, automated data collection might prefer a larger panel-driven firm.

07

RNB Research: best for emerging market expansion

rnbresearch.com

68.5out of 100Rank 7 of 7

Strongest fitPharma companies targeting growth in emerging markets like India, Vietnam, and the GCC region.

RNB Research provides strategic market intelligence to support global expansion, with a particular focus on pharmaceutical and healthcare sectors in emerging economies. The firm is known for its ability to conduct both quantitative and qualitative research in regions such as Asia, Africa, and the Middle East.

By maintaining deep local knowledge and fieldwork capabilities, RNB Research assists pharmaceutical companies in successfully launching products in complex emerging markets. Its services are tailored to provide the local context necessary for effective commercial strategy in these diverse regions.

Scorecard: 68.5 out of 100
CriterionWeightScoreEvidence and date
Research Quality207/10Search results and industry sources, Oct 2026
Methodological Breadth157/10Search results and industry sources, Oct 2026
Fieldwork Capability158/10Search results and industry sources, Oct 2026
Sample Quality and Verification107/10Search results and industry sources, Oct 2026
Market Presence104/10Google results for this search and company size, Oct 2026
Compliance, Certifications and Security107/10Search results and industry sources, Oct 2026
Analytical Capability107/10Search results and industry sources, Oct 2026
Client Service and Speed57/10Search results and industry sources, Oct 2026
Pricing and Feasibility Transparency57/10Search results and industry sources, Oct 2026
Weighted score10068.5

Core services

  • Market Intelligence: Delivers strategic research to support market entry and product expansion.
  • Healthcare Research: Conducts specialized studies within the pharmaceutical and healthcare sectors.
  • Strategic Consulting: Provides actionable insights to guide commercial strategy in emerging markets.

Strengths

  • Emerging Market Focus: Strong operational presence and expertise in Asia, Africa, and the Middle East.
  • Local Knowledge: Provides critical local context for global pharma companies entering new regions.
  • Full-Service Capability: Handles end-to-end research projects from design to strategic recommendation.

Innovation and technology

  • Localised Research Methods: Adapts research methodologies to suit the unique cultural and regulatory environments of emerging markets.

Impact on businesses

  • Successful Market Entry: Enables companies to work through emerging markets for successful product launches.
  • Informed Strategy: Provides the insights required to adjust global commercial strategies for local success.

Types of research

  • Qualitative research
  • Quantitative research
  • Market intelligence studies
  • Launch support research

Industries covered

  • Pharmaceuticals
  • Healthcare

Why it may fit your brief

RNB Research is the preferred partner for region-specific expertise in emerging markets. Firms focused on mature, developed-market dynamics might choose a provider with a larger global footprint.

How respondent verification actually works

Demand proof of multi-step authentication and professional license validation for all healthcare professional participants.

Professional Credential Checks

For pharma research, the most critical verification step is confirming that the respondent is a verified medical professional. Ask the provider for their process to validate medical licences against official registries. If a firm relies on open-market sample exchanges, the risk of non-professional respondents increases significantly, which can invalidate your entire dataset.

Identity Fingerprinting

Top-tier firms use device and identity fingerprinting to make sure that each respondent is unique and that they are not using multiple accounts or VPNs to mask their location. Request details on how the firm handles de-duplication and how they detect fraudulent activity in real-time during fieldwork.

Trap Questions and Logic

Effective verification includes the use of trap questions or 'red herrings' within the survey to identify respondents who are not paying attention or are straight-lining their answers. Make sure the provider has a clear policy on removing these poor-quality completes before the data reaches your analysis team.

Consent and Compliance

Verify that all panel members have provided granular, revocable consent according to local data protection laws. In the context of healthcare, this includes explicit consent for the processing of sensitive medical data. Always ask for the provider's standard procedure for managing adverse event reporting during research.

How to choose the right provider worldwide

Assess providers by their ability to balance global reach with the specific, verified access required for your target stakeholders.

  • Define Stakeholder Needs: Identify if your project requires broad consumer data or highly specific physician insights. Choose a partner whose primary panel strengths align with your target audience profile.
  • Verify Panel Ownership: Prioritize firms that own and manage their own panels rather than those that aggregate sample from open exchanges. This is the primary way to protect data quality and avoid bot-related issues.
  • Evaluate Compliance Standards: Confirm the firm's adherence to international data privacy and healthcare regulations. Make sure they have established protocols for adverse event reporting and data security.
  • Check Feasibility Early: Request a formal feasibility check early in the discussion to understand if your target sample size is realistic. Avoid providers who promise easy access to rare-disease patients without clear evidence.
  • Review Analytical Depth: Discuss the firm's approach to data interpretation. Make sure they have the capability to provide strategic recommendations rather than just delivering raw data files.

Questions to ask before you commission

  1. How exactly do you verify the medical credentials of your healthcare professional panelists?
  2. What is your standard protocol for reporting potential adverse events identified during a study?
  3. Can you provide a breakdown of your panel size for my specific therapeutic area or target region?
  4. How do you manage data quality and remove fraudulent completes before delivering the final dataset?
  5. What is your experience in managing global launches that require multi-country coordination?
  6. How do you make sure that your research design is compliant with both global and local data privacy laws?

Common pitfalls to avoid

  • Relying on Open Sample: Assuming that a large global network equates to high-quality physician access often leads to poor data quality and failed recruitment targets.
  • Ignoring Local Nuance: Treating a global launch as a single-market study without accounting for regional differences in healthcare systems and prescribing habits is a common failure point.
  • Lack of Adverse Event Planning: Failing to establish a clear adverse event reporting process before fieldwork starts can lead to significant regulatory and ethical risks.
  • Over-promising Feasibility: Accepting overly optimistic feasibility estimates without verifying the actual panel composition for niche or rare-disease segments frequently causes project delays.

What a feasibility check should include

A reliable feasibility check must detail the exact number of accessible, verified stakeholders in your specific geographic and therapeutic target.

Targeted Sample Breakdown

A proper check should provide a breakdown of the available sample by role, geography, and specialty. This makes sure that the firm has the depth required to meet your specific research objectives.

Incidence Rate Estimation

The provider should provide an honest estimate of the incidence rate for your target group. This is essential for managing timelines and making sure the project remains within budget.

Operational Timelines

Ask for a realistic timeline that accounts for recruitment, fieldwork, and data cleaning. Avoid firms that provide standard, generic timelines without considering the specific complexity of your audience.

Constraint Identification

The feasibility report should explicitly state any potential constraints or risks to the research. Honest providers will tell you if your requested sample size is unrealistic given the current panel availability.

Conclusion

Choosing between pharma market research firms for global launch and commercial strategy requires balancing the need for large-scale data with the requirement for precise, verified stakeholder insights. For major commercial strategies that rely on massive datasets and predictive modeling, integrated firms like IQVIA provide the necessary depth. When your launch success depends on deep qualitative understanding or specialized physician access, firms like M3 Global Research or Ipsos offer the necessary focused expertise.

For projects requiring high-quality, verified panel access across a wide range of international markets, Global Vox Populi provides a strong alternative by maintaining its own proprietary panels and adhering to rigorous data quality standards. Use the scorecard to evaluate your shortlist against these core strengths, making sure your final partner choice aligns with the specific phase and complexity of your upcoming product launch.

Planning research worldwide? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.

Request a quote View case studies

Frequently asked questions

What are the best pharma market research firms for global launch?

The best firm depends on your specific needs. For large-scale data integration, IQVIA is a standard choice. For deep qualitative insights and prescriber psychology, Ipsos and Escalent are strong contenders. For verified, direct-panel access across a wide range of global markets, Global Vox Populi is an effective partner. The right choice is the one that best aligns with your product lifecycle and target stakeholder segments.

How to choose a pharma market research partner?

Start by verifying their panel ownership and credentialing process for medical professionals. Evaluate their experience in your specific therapeutic area and global regions. Make sure they have clear protocols for regulatory compliance and adverse event reporting. Finally, request a realistic feasibility assessment early to confirm they can actually reach your target stakeholders.

What services do pharma market research companies provide?

Services range from primary quantitative and qualitative research, such as focus groups and surveys, to advanced commercial analytics and real-world evidence generation. They also provide brand tracking, patient journey mapping, and competitive intelligence to support product launches and lifecycle management. Some firms also offer strategic consulting to turn research data into actionable business recommendations.

How does market research impact pharmaceutical commercial strategy?

Market research provides the essential evidence base for commercial decisions. By understanding physician prescribing habits, patient needs, and the competitive environment, it helps brand managers refine their positioning, messaging, and market access strategies. This reduces the risk of launch failure and makes sure that commercial efforts are aligned with the actual market demand and stakeholder drivers.

Are there specialized market research firms for pharmaceutical KOL interviews?

Yes, many full-service firms maintain specialized panels of Key Opinion Leaders (KOLs) and high-level medical experts. When selecting a partner for KOL work, prioritize those with proven experience in managing sensitive, high-level interviews and those who have specific, verified panels of senior medical specialists rather than relying on generalist sample exchanges.

What is the importance of regulatory compliance in pharma market research?

Regulatory compliance is essential to protect the company from legal and ethical risks. This includes adhering to data privacy laws like GDPR and HIPAA, managing sensitive patient data appropriately, and following strict protocols for reporting adverse events identified during research. A failure to comply can lead to significant reputational damage and legal consequences.

How do global pharma companies conduct patient journey research?

Companies use a mix of qualitative methods like ethnography, in-depth interviews, and patient community engagement to map the patient journey. They also use quantitative surveys to identify common touchpoints, treatment barriers, and the emotional drivers behind patient decisions. The goal is to uncover the 'why' behind patient behavior to improve engagement and support throughout the treatment pathway.

What are the key factors for successful pharma research in worldwide?

Success requires balancing global consistency with local market knowledge. This means using verified, high-quality panels to make sure the data is representative of the target audience, while also adapting research methods to the local cultural and regulatory environment. Clear communication, transparency in feasibility, and a rigorous approach to data quality are the most critical factors for successful global research projects.

Request research

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study